Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Juan

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|May 18, 1999
Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)O Juan, A Lluch, L de Paz, et al.
Revista Clinica Espanola|July 28, 2004
[Relationship between cholesterol and fibrinogen in two populations of different geographical location of Catalonia]J J Rodríguez Cristóbal, C A Villaverde Grote, N Tibau Llardén, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2018
SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)M Majem, O Juan, A Insa, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II studyF Cardenal, M Domine, B Massutí, et al.
Cancer Epidemiology|March 14, 2015
Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON studyE Esteban, M Majem, M Martinez Aguillo, et al.
European Journal of Cancer Care|December 17, 2008
Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain--results of the LEARN StudyD Almenar, J Mayans, O Juan, et al.
World Journal of Clinical Oncology|August 11, 2022
Current treatment landscape for oligometastatic non-small cell lung cancerJavier Garde-Noguera, Margarita Martín-Martín, Andres Obeso, et al.
The American Journal of Cardiology|December 28, 2010
Specific characteristics of sudden death in a mediterranean Spanish populationM Teresa Subirana, Josep O Juan-Babot, Teresa Puig, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2017
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 databaseJ Remon, D Isla, P Garrido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331<sup>☆</sup>D R Spigel, D Vicente, T E Ciuleanu, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|May 18, 1999
Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)O Juan, A Lluch, L de Paz, et al.
Revista Clinica Espanola|July 28, 2004
[Relationship between cholesterol and fibrinogen in two populations of different geographical location of Catalonia]J J Rodríguez Cristóbal, C A Villaverde Grote, N Tibau Llardén, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2018
SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)M Majem, O Juan, A Insa, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II studyF Cardenal, M Domine, B Massutí, et al.
Cancer Epidemiology|March 14, 2015
Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON studyE Esteban, M Majem, M Martinez Aguillo, et al.
European Journal of Cancer Care|December 17, 2008
Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain--results of the LEARN StudyD Almenar, J Mayans, O Juan, et al.
World Journal of Clinical Oncology|August 11, 2022
Current treatment landscape for oligometastatic non-small cell lung cancerJavier Garde-Noguera, Margarita Martín-Martín, Andres Obeso, et al.
The American Journal of Cardiology|December 28, 2010
Specific characteristics of sudden death in a mediterranean Spanish populationM Teresa Subirana, Josep O Juan-Babot, Teresa Puig, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2017
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 databaseJ Remon, D Isla, P Garrido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331<sup>☆</sup>D R Spigel, D Vicente, T E Ciuleanu, et al.
Pageof 5